EI-1941-1 and -2, novel interleukin-1β converting enzyme inhibitors produced by Farrowia sp. E-1941. I. Biochemical characterization of EI-1941-1 and -2

Journal of Antibiotics

Volumn 56, Issue 5, 2003, Pages 464-469

  Koizumi, Fumito ^a   Matsuda, Yuzuru ^a   Nakanishi, Satoshi ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; EI 1941 1; EI 1941 2; ELASTASE; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOCHEMISTRY; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FARROWIA; HUMAN; HUMAN CELL; IC 50; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

FARROWIA;

EID: 0038171274     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.464     Document Type: Article

References (16)

1. THORNBERRY, N. A.; H. G. BULL, J. R. CALAYCAY, K. T. CHAPMAN, A. D. HOWARD, M. J. KOSTURA, D. K. MILLER, S. M. MOLINEAUX, J. R. WEIDNER, J. AUNINS, K. O. ELLISTON, J. M. AYALA, F. J. CASANO, J. CHIN, G. J.-F. DING, L. A. EGGER, E. P. GAFFNEY, G. LIMJUCO, O. C. PALYHA, S. M. RAJU, A. M. ROLANDO, J. P. SALLEY, T.-T. YAMIN, T. D. LEE, J. E. SHIVELY, M. MACCROSS, R. A. MUMFORD, J. A. SCHMIDT & M. J. TOCCI: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768-774, 1992
2. GERRETTI, D. P.; C. J. KOZLOSKY, B. MOSLEY, N. NELSON, K. V. NESS, T. A. GREENSTREET, C. J. MARCH, S. R. KRONHEIM, T. DRUCK, L. A. CANNIZZARO, K. HUEBNER & R. A. BLACK: Molecular cloning of the interleukin-1β converting enzyme. Science 256: 97-100, 1992
3. DINARELLO, C. A.: Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991
4. DINARELLO, C. A. & S. M. WOLFF: The role of interleukin-1 in disease. N. Engl. J. Med. 328: 106-113, 1993
5. TSUKUDA, E.; T. TANAKA, K. OCHIAI, H. KONDO, M. YOSHIDA, T. AGATSUMA, Y. SAITOH, S. TESHIBA & Y. MATSUDA: EI-1507-1 and -2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1507. J. Antibiotics 49: 333-339, 1996
6. TANAKA, T.; E. TSUKUDA, K. OCHIAI, H. KONDO, S. TESHIBA & Y. MATSUDA: EI-1511-3, -5 and El-1625-2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. I. Taxonomy of producing strain, fermentation and isolation. J. Antibiotics 49: 1073-1078, 1996
7. UOSAKI, Y.; T. AGATSUMA, T. TANAKA & Y. SAITOH: EI-1511-3, -5 and EI-1625-2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. II. Structure determination. J. Antibiotics 49: 1079-1084, 1996
8. TANAKA, T.; E. TSUKUDA, Y. UOSAKI & Y. MATSUDA: EI-1511-3, -5 and EI-1625-2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. III. Biochemical properties of EI-1511-3, -5 and EI-1625-2. J. Antibiotics 49: 1085-1090, 1996
9. KOIZUMI, F.; H. ISHIGURO, K. ANDO, H. KONDO, M. YOSHIDA, Y. MATSUDA & S. NAKANISHI: J. Antibiotics, in preparation
10. 2, homodimer. Cell 78: 343-352, 1994
11. BARRETT, A. J. & H. KIRSCHKE: Cathepsin B, cathepsin H and cathepsin L. In Methods in Enzymol. Vol. 80 Proteolytic enzymes. Part C. Ed., L. LORAND, pp. 535-561, Academic Press, New York, 1981
12. MUMFORD, R. A.; A. W. STRAUSS, J. C. POWERS, P. A. PIERZCHALA, N. NISHINO & M. MIMMERMAN: A zinc methalloendopeptidase associated with dog pancreatic membranes. J. Biol. Chem. 255: 2227-2230, 1980
13. MOSMANN, T.: Colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immnol. Methods 65: 55-63, 1983
14. GEHRT, A.; G. ERKEL, H. ANKE, T. ANKE & O. STERNER: New hexaketide inhibitors of eukaryotic signal transduction. Natl. Prod. Lett. 9: 259-264, 1997
15. GEHRT, A.; G. ERKEL, T. ANKE & O. STERNER: Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3 -pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction. J. Antibiotics 51: 455-463, 1998
16. BAEUERLE, P, A. & T. HENKEL: Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179, 1994